Search results
Moderna, Inc. (NASDAQ:MRNA) Expected to Earn Q3 2025 Earnings of $1.30 Per Share
ETF DAILY NEWS· 1 day agoModerna, Inc. (NASDAQ:MRNA – Free Report) – Equities research analysts at William Blair lifted their Q3 2025 EPS estimates for Moderna in a report released ...
Unveiling Moderna (MRNA)'s Value: Is It Really Priced Right? A C
Guru Focus· 13 hours agoToday, Moderna Inc (MRNA, Financial) experienced a stock price decline of 3.43%, yet it has seen a significant three-month gain of 28.21%. With a current Loss Per Share standing ...
Moderna Inc (MRNA)'s Uncertain Future: Understanding the Barrier
Guru Focus· 12 hours agoLong-established in the Biotechnology industry, Moderna Inc (MRNA, Financial) has enjoyed a stellar reputation. Notably, its diminished rankings in financial strength, growth ...
Moderna's Options Frenzy: What You Need to Know - Moderna (NASDAQ:MRNA)
Benzinga· 14 hours agoLoading... Loading... Deep-pocketed investors have adopted a bullish approach towards Moderna MRNA , and it's something market players shouldn't ignore. Our tracking of public ...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 5 days agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna Puts Up Big Quarterly Beat; Could Shares Break Out?
Investor's Business Daily· 5 days agoModerna (MRNA) beat Wall Street's first-quarter expectations Thursday. The Covid vaccine maker came...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 5 days agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 4 days agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Earnings call: Moderna reports a net loss of $12.2 billion By Investing.com
Investing.com· 4 days agoModerna , Inc. (NASDAQ:MRNA) reported a mixed first quarter in 2024, with significant business...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoModerna stock broke out for the first time in over a year on May 2 after the biotech company notched...